Results 91 to 100 of about 9,080 (215)
ACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Leonardo Rodrigues Campos +6 more
wiley +1 more source
Upper Jaw Mucormycosis in an Immunocompetent Patient: A Clinical Report
Case Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.Mucormycosis is a rare but severe opportunistic infection, whose incidence has substantially increased since the coronavirus disease 2019 (COVID‐19) pandemic. It predominantly affects immunocompromised patients, individuals with diabetes, and those receiving corticosteroids.
Chloé Thepenier +6 more
wiley +1 more source
Journal of Diabetes Research, Volume 2026, Issue 1, 2026.Aims This retrospective study is aimed at evaluating the effect of SGLT2 inhibitors (SGLT2i) on the risk of sepsis among patients with Type 2 diabetes mellitus (T2DM). Materials and Methods An active‐comparator new user design was utilized based on Taiwan′s National Health Insurance Research Database. Adult patients diagnosed with T2DM between 2017 and
Chun-Ying Wu +8 more
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 12, December 2025.ABSTRACT Rhino‐orbital‐cerebral mucormycosis (ROCM) is a rare but highly lethal fungal infection that typically occurs in patients with classical immunosuppressive states. This report presents a case of ROCM in a 27‐year‐old male whose sole systemic risk factor was chronic Hepatitis B (HBV) and Hepatitis D (HDV) coinfection.
Fazeela Bibi +7 more
wiley +1 more source
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi [PDF]
, 2017 Isavuconazole, the active moiety of the water-soluble prodrug isavuconazonium sulfate, is a triazole antifungal agent for the treatment of invasive fungal infections.
Andes, David +8 more
core +3 more sources
Clinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1405-1421, December 2025.Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami +2 more
wiley +1 more source
Case Reports in Infectious Diseases, 2015 Pulmonary mucormycosis is commonly encountered in patients with diabetic ketoacidosis, hematologic malignancies, neutropenia, organ or hematopoietic stem cell transplantation, and malignancy, but it rarely occurs in high-risk patients with systemic lupus
Hung-Chang Hung +6 more
doaj +1 more source
Medical Mycology Case Reports, 2017 Mucormycosis is a life threatening infection caused by fungi in the order Mucorales. Mucormycosis can affect any organ system with rhino-orbital-cerebral and pulmonary infections being the most predominant infection types.
Anthony Anderson +5 more
doaj +1 more source
A significant number of reported Absidia corymbifera (Lichtheimia corymbifera) infections are caused by Lictheimia ramosa (syn. Lichtheimia hongkongensis): an emerging cause of mucormycosis [PDF]
, 2012 published_or_final_versio
Lau, SKP +4 more
core +1 more source